- Home
- HONE vs UPB Comparison
HONE vs UPB Comparison
Compare HONE & UPB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HONE
- UPB
- Stock Information
- Founded
- HONE 1917
- UPB 2021
- Country
- HONE United States
- UPB United States
- Employees
- HONE N/A
- UPB N/A
- Industry
- HONE Major Banks
- UPB
- Sector
- HONE Finance
- UPB
- Exchange
- HONE Nasdaq
- UPB NYSE
- Market Cap
- HONE 472.7M
- UPB 521.3M
- IPO Year
- HONE 2016
- UPB 2024
- Fundamental
- Price
- HONE $11.68
- UPB $11.19
- Analyst Decision
- HONE Buy
- UPB Strong Buy
- Analyst Count
- HONE 3
- UPB 4
- Target Price
- HONE $14.50
- UPB $56.50
- AVG Volume (30 Days)
- HONE 344.1K
- UPB 536.5K
- Earning Date
- HONE 07-24-2025
- UPB 08-14-2025
- Dividend Yield
- HONE 3.10%
- UPB N/A
- EPS Growth
- HONE 67.30
- UPB N/A
- EPS
- HONE 0.63
- UPB N/A
- Revenue
- HONE $162,776,000.00
- UPB $2,296,000.00
- Revenue This Year
- HONE N/A
- UPB N/A
- Revenue Next Year
- HONE $9.44
- UPB N/A
- P/E Ratio
- HONE $18.50
- UPB N/A
- Revenue Growth
- HONE N/A
- UPB N/A
- 52 Week Low
- HONE $8.89
- UPB $5.14
- 52 Week High
- HONE $14.00
- UPB $29.46
- Technical
- Relative Strength Index (RSI)
- HONE 58.11
- UPB N/A
- Support Level
- HONE $10.57
- UPB N/A
- Resistance Level
- HONE $11.53
- UPB N/A
- Average True Range (ATR)
- HONE 0.29
- UPB 0.00
- MACD
- HONE 0.02
- UPB 0.00
- Stochastic Oscillator
- HONE 89.57
- UPB 0.00
About HONE HarborOne Bancorp Inc.
HarborOne Bancorp Inc is a bank holding company. The company is engaged in providing financial services like accepting deposits, lending loans, online and mobile banking, cash management, credit cards, money market accounts, and wealth management. The Company has two reportable segments: HarborOne Bank and HarborOne Mortgage. The bank provides financial services to individuals and businesses online and through its full-service branches located in Massachusetts and Rhode Island, one limited-service branch, and a commercial lending office in Boston, Massachusetts, and Providence, Rhode Island.
About UPB UPSTREAM BIO INC
Upstream Bio Inc is a clinical-stage biotechnology company developing treatments for inflammatory diseases, with an initial focus on severe respiratory disorders. It is developing verekitug, the known antagonist currently in clinical development that targets the receptor for Thymic Stromal Lymphopoietin (TSLP), a cytokine that is a clinically validated driver of inflammatory response positioned upstream of multiple signaling cascades that affect a variety of immune-mediated diseases.